vs
Side-by-side financial comparison of Anika Therapeutics, Inc. (ANIK) and American Express (AXP). Click either name above to swap in a different company.
Anika Therapeutics, Inc. is the larger business by last-quarter revenue ($29.6M vs $18.9M, roughly 1.6× American Express). On growth, Anika Therapeutics, Inc. posted the faster year-over-year revenue change (13.2% vs 11.4%). Over the past eight quarters, Anika Therapeutics, Inc.'s revenue compounded faster (-1.8% CAGR vs -95.6%).
American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products an...
ANIK vs AXP — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $29.6M | $18.9M |
| Net Profit | — | $3.0M |
| Gross Margin | 64.2% | — |
| Operating Margin | 17.3% | — |
| Net Margin | — | 15.7% |
| Revenue YoY | 13.2% | 11.4% |
| Net Profit YoY | — | 15.0% |
| EPS (diluted) | $0.27 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $29.6M | $18.9M | ||
| Q4 25 | $30.6M | $10.9B | ||
| Q3 25 | $27.8M | $10.4B | ||
| Q2 25 | $28.2M | $10.3B | ||
| Q1 25 | $26.2M | $9.6B | ||
| Q4 24 | $30.6M | $10.0B | ||
| Q3 24 | $29.6M | $9.7B | ||
| Q2 24 | $30.7M | $9.8B |
| Q1 26 | — | $3.0M | ||
| Q4 25 | $292.0K | $2.5B | ||
| Q3 25 | $-2.3M | $2.9B | ||
| Q2 25 | $-4.0M | $2.9B | ||
| Q1 25 | $-4.9M | $2.6B | ||
| Q4 24 | $-21.9M | $2.2B | ||
| Q3 24 | $-29.9M | $2.5B | ||
| Q2 24 | $-88.0K | $3.0B |
| Q1 26 | 64.2% | — | ||
| Q4 25 | 62.6% | — | ||
| Q3 25 | 56.0% | — | ||
| Q2 25 | 50.9% | — | ||
| Q1 25 | 56.1% | — | ||
| Q4 24 | 56.0% | — | ||
| Q3 24 | 65.7% | — | ||
| Q2 24 | 66.7% | — |
| Q1 26 | 17.3% | — | ||
| Q4 25 | 2.1% | 28.2% | ||
| Q3 25 | -11.6% | 36.7% | ||
| Q2 25 | -14.8% | 34.4% | ||
| Q1 25 | -16.4% | 34.6% | ||
| Q4 24 | -2.3% | 27.7% | ||
| Q3 24 | -0.3% | 33.0% | ||
| Q2 24 | -5.9% | 38.6% |
| Q1 26 | — | 15.7% | ||
| Q4 25 | 1.0% | 22.5% | ||
| Q3 25 | -8.4% | 27.9% | ||
| Q2 25 | -14.1% | 28.0% | ||
| Q1 25 | -18.6% | 26.8% | ||
| Q4 24 | -71.4% | 21.8% | ||
| Q3 24 | -101.2% | 25.8% | ||
| Q2 24 | -0.3% | 30.7% |
| Q1 26 | $0.27 | — | ||
| Q4 25 | $0.02 | $3.52 | ||
| Q3 25 | $-0.16 | $4.14 | ||
| Q2 25 | $-0.28 | $4.08 | ||
| Q1 25 | $-0.34 | $3.64 | ||
| Q4 24 | $-1.49 | $3.04 | ||
| Q3 24 | $-2.03 | $3.49 | ||
| Q2 24 | $0.00 | $4.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.0M | — |
| Total DebtLower is stronger | — | $60.4M |
| Stockholders' EquityBook value | $133.9M | $34.0M |
| Total Assets | $179.4M | $308.9M |
| Debt / EquityLower = less leverage | — | 1.78× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $41.0M | — | ||
| Q4 25 | $81.2M | $742.0M | ||
| Q3 25 | $80.2M | $1.3B | ||
| Q2 25 | $77.1M | $197.0M | ||
| Q1 25 | $75.4M | $261.0M | ||
| Q4 24 | $79.2M | $221.0M | ||
| Q3 24 | $90.7M | $120.0M | ||
| Q2 24 | $96.6M | $188.0M |
| Q1 26 | — | $60.4M | ||
| Q4 25 | — | $56.4B | ||
| Q3 25 | — | $57.8B | ||
| Q2 25 | — | $58.2B | ||
| Q1 25 | — | $51.2B | ||
| Q4 24 | — | $49.7B | ||
| Q3 24 | — | $53.5B | ||
| Q2 24 | — | $51.5B |
| Q1 26 | $133.9M | $34.0M | ||
| Q4 25 | $143.5M | $33.5B | ||
| Q3 25 | $146.8M | $32.4B | ||
| Q2 25 | $147.7M | $32.3B | ||
| Q1 25 | $148.4M | $31.2B | ||
| Q4 24 | $154.0M | $30.3B | ||
| Q3 24 | $179.9M | $29.7B | ||
| Q2 24 | $210.3M | $29.5B |
| Q1 26 | $179.4M | $308.9M | ||
| Q4 25 | $190.3M | $300.1B | ||
| Q3 25 | $189.4M | $297.6B | ||
| Q2 25 | $187.7M | $295.6B | ||
| Q1 25 | $190.6M | $282.2B | ||
| Q4 24 | $202.7M | $271.5B | ||
| Q3 24 | $231.4M | $271.0B | ||
| Q2 24 | $262.7M | $272.2B |
| Q1 26 | — | 1.78× | ||
| Q4 25 | — | 1.68× | ||
| Q3 25 | — | 1.78× | ||
| Q2 25 | — | 1.80× | ||
| Q1 25 | — | 1.64× | ||
| Q4 24 | — | 1.64× | ||
| Q3 24 | — | 1.80× | ||
| Q2 24 | — | 1.74× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANIK
| OEM Channel | $17.0M | 57% |
| Commercial Channel | $12.6M | 43% |
AXP
| Discount revenue | $9.5M | 50% |
| Other | $8.9M | 47% |
| Deposits with banks and other | $512.0K | 3% |
